ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung Cancer.

Oladimeji Akinboro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.